HeartBeam (BEAT) EBITDA (2020 - 2026)

HeartBeam (BEAT) has 7 years of EBITDA data on file, last reported at -$4.7 million in Q1 2026.

• On a quarterly basis, EBITDA rose 14.32% year-over-year to -$4.7 million in Q1 2026; TTM through Mar 2026 was -$20.4 million, a 1.23% increase from a year earlier, with the FY2025 full-year figure at -$21.1 million, down 6.3% from the prior year.
• EBITDA for Q1 2026 stood at -$4.7 million, up from -$5.3 million in the prior quarter.
• Over the last five years, EBITDA for BEAT reached as high as -$2.1 million in Q1 2022 and fell as low as -$5.5 million in Q1 2025.
• Historically, EBITDA has averaged -$4.4 million across 5 years, with a median of -$4.7 million in 2026.
• Across the five-year window, EBITDA slumped 1217.79% in 2022 and gained 14.32% in 2026, its largest moves.
• Year by year, EBITDA stood at -$3.7 million in 2022, then retreated by 9.9% to -$4.1 million in 2023, then fell by 20.32% to -$4.9 million in 2024, then dropped by 7.4% to -$5.3 million in 2025, then rose by 11.19% to -$4.7 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$4.7 million in Q1 2026, -$5.3 million in Q4 2025, and -$5.3 million in Q3 2025.